Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation.
Journal: Blood cancer discovery
Published: December 06, 2024
Azacitidine and venetoclax for the treatment of AML arising from an underlying telomere biology disorder.
Journal: Familial cancer
Published: September 14, 2024
Reducing unnecessary outpatient group and screen testing at a regional cancer center.
Journal: Transfusion
Published: May 21, 2024
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML.
Journal: bioRxiv : the preprint server for biology
Published: January 18, 2024
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.
Journal: Blood advances
Published: September 20, 2023
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor.
Journal: American journal of hematology
Published: December 06, 2022
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
Journal: Leukemia
Published: September 14, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Journal: Blood
Published: December 20, 2021
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort.
Journal: Leukemia
Published: December 18, 2021
Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Journal: Cell reports
Published: August 09, 2021
Last Updated: 09/26/2026